Dr. Javier Baena Espinar | Cancer | Best Research Article Award
Medical Oncologist | Hospital 12 de Octubre | Spain
Dr. Javier Baena Espinar is a dedicated clinical researcher and medical oncologist specializing in thoracic oncology, immunotherapy, and real-world evidence studies, with 891 citations across 807 documents, 27 scientific papers, and an h-index of 11. His work spans global cancer registries, multicenter collaborations, and translational research aimed at advancing precision medicine in lung cancer. Academic development includes advanced oncology training and continuous specialization in thoracic cancer and emerging therapeutics. Professional experience includes contributions to major registries, real-world immunotherapy analyses, biomarker-driven treatment studies, and multidisciplinary clinical projects across national and international platforms. Research interests encompass NSCLC, SCLC, biomarker-guided therapy, immune checkpoint inhibitor safety, KRAS-targeted strategies, ALK/ROS1 alterations, and the clinical utility of next-generation sequencing, with notable input to global datasets evaluating treatment outcomes and infectious disease impact in cancer. His scientific contributions and collaborative work have been recognized by oncology research groups and academic organizations.
Profiles : Scopus | ORCID
Featured Publications
Baena Espinar, J. (2025). Clinical utility of combined tissue and plasma next-generation sequencing in patients with advanced, treatment-naïve NSCLC. JTO Clinical and Research Reports.
Baena Espinar, J. (2025). Determinants of 5-year survival in advanced NSCLC with PD-L1 ≥50% treated with first-line pembrolizumab: Pembro-real 5Y global registry. Journal for Immunotherapy of Cancer.
Baena Espinar, J. (2025). Efficacy and safety of lorlatinib in ALK- and ROS1-rearranged metastatic NSCLC in the Spanish compassionate use program. Scientific Paper.
Baena Espinar, J. (2025). Safety and effectiveness of SARS-CoV-2 vaccination in patients with lung cancer. Scientific Paper.
Baena Espinar, J. (2025). Safety and efficacy of immune checkpoint therapy in patients with cardiac metastasis: Multicenter international retrospective study. Scientific Paper.